Literature DB >> 19220190

Ocular pigmentation associated with clozapine.

Armand M Borovik1, Martina M Bosch, Stephanie L Watson.   

Abstract

A 55-year-old woman who was treated with long-term, high-dose clozapine for schizophrenia presented with bilateral decreased visual acuity. She had pigmentary changes affecting the cornea and the retina, as well as stellate cataract. Chlorpromazine use is known to produce similar changes, but this is the first report to our knowledge of pigmentation associated with clozapine use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220190     DOI: 10.5694/j.1326-5377.2009.tb02353.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features.

Authors:  Céline Faure; Isabelle Audo; Christina Zeitz; Jean-Bernard Letessier; Matthieu P Robert
Journal:  Doc Ophthalmol       Date:  2015-03-20       Impact factor: 2.379

2.  A Case Report: Anti-Psychotic Agents Related Ocular Toxicity.

Authors:  Bonnie Nga Kwan Choy; Alex Lap Ki Ng; Jennifer Wei Huen Shum; Michelle Ching Yim Fan; Jimmy Shiu Ming Lai
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Clozapine-induced cataract in a young female.

Authors:  Md Shahid Alam; K V Praveen Kumar
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.